Proteogenix는 Primary Antibody Biosimilar - Research Grade
제품을 전문적으로 생산하는 20년의 경험이 있는 High Quality 제조사입니다.
제품 설명
제품 번호
PTXCOV-A554
제품 특징
| Product name | Anti-RBD-6 antibody (VHH-72) |
|---|---|
| Species | Human |
| Expression system | Mammalian |
| Molecular weight | 39,2kDa |
| Purity | 85% |
| Buffer | PBS, pH7,5 |
| Form | Liquid |
| Delivery condition | Blue ice (+4°C) |
| Storage condition | 4°C for short term; -20°c or -80°C for long term |
| Brand | Proteogenix |
| Aliases /Synonyms | VHH-72 antibody |
| Reference | PTXCOV-A554 |
| Note | For research use only. Not suitable for in vitro diagnostic and human use. |
| Isotype | IgG1 |
| Clonality | Monoclonal Antibody |
| Target | RBD domain- SARS-CoV2 Spike protein |
Antibody anti-RBD-6 is a single-domain camelid heavy chain immunoglobulin (VHH, nanobody). It was developed by immunizing a llama with stabilized spike proteins from coronaviruses MERS-CoV and SARS-CoV-1. After immunization and development of a measurable immune response, the RNA was isolated from the peripheral blood mononuclear cells (PBMCs) and used as a template for cDNA synthesis and amplification of the antibody genes.
The resulting library of antibodies was screened by phage display with Escherichia coli and M13 helper phages against the spike protein of SARS-CoV-1. Binders with the highest affinity were screened for cross-reactivity with the spike protein of the new coronavirus and selected for further studies. The anti-RBD-6 antibody displayed a high affinity towards the spike proteins of SARS-CoV-1 and SARS-CoV-2. Crystallization studies further revealed this antibody binds a conserved region of the receptor-binding domain (RBD) shared between the two SARS strains. Additional studies with pseudotyped viral particles showed that the anti-RBD-6 antibody in a monovalent format (VHH) displayed only a mild neutralizing activity against these viruses.
Due to its initially feeble activity, the monovalent VHH was further engineered into a bivalent conformation (VHH-VHH). This format succeeded in enhancing this molecule’s neutralizing activity.
VHH antibodies are valuable reagents due to their enhanced chemo and thermostability in comparison to conventional antibodies. They are also easier to produce in vitro due to the absence of glycans on their surface. Moreover, they display higher diffusion rates making their ideal reagents for diagnostics and therapeutic applications. In this context, this bivalent VHH molecule can serve to investigate SARS-CoV-2 mechanisms of infection, develop robust in vitro diagnostic tools, and used for medical imaging when conjugated with the adequate molecular markers.
QC & Validation Data
Anti-RBD-6 antibody (VHH-72), on SDS-PAGE under reducing and non-reducing conditions. The gel was stained overnight with Coomassie Blue. The purity of the protein is greater than 95%.
ProteoGenix의 모든 제품들을 만나보세요!
Proteogenix - Exclusive Distributor in South Korea "Morebio" 한국 독점 대리점 "모아바이오"
MSDS
온라인 견적
